Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma

Condition:   Neuroblastoma Intervention:   Biological: GD2 CAR T cells Sponsor:   University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials